摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 4-methoxybenzimidate hydrochloride | 54998-29-7

中文名称
——
中文别名
——
英文名称
ethyl 4-methoxybenzimidate hydrochloride
英文别名
ethyl 4-methoxybenzenecarboximidate;hydrochloride
ethyl 4-methoxybenzimidate hydrochloride化学式
CAS
54998-29-7
化学式
C10H13NO2*ClH
mdl
——
分子量
215.68
InChiKey
VPJFORIZDKSQBF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.48
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    42.3
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2925290090
  • 储存条件:
    室温,惰性气氛环境下

SDS

SDS:1eca9200d12018f2f86f950ccf1b7f83
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: Ethyl 4-methoxybenzenecarboximidate hydrochloride
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: Ethyl 4-methoxybenzenecarboximidate hydrochloride
CAS number: 54998-29-7

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H14ClNO2
Molecular weight: 215.7

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    ethyl 4-methoxybenzimidate hydrochloride 作用下, 以 乙醇 为溶剂, 反应 3.0h, 以75%的产率得到4-甲氧基苄脒盐酸盐
    参考文献:
    名称:
    Pischel, Helmut; Holy, Antonin; Wagner, Guenther, Collection of Czechoslovak Chemical Communications, 1981, vol. 46, # 4, p. 933 - 940
    摘要:
    DOI:
  • 作为产物:
    描述:
    4-甲氧基苯甲腈盐酸 作用下, 以 乙醇 为溶剂, 以40.5 g (94%)的产率得到ethyl 4-methoxybenzimidate hydrochloride
    参考文献:
    名称:
    Heterocyclic amide compounds and pharmaceutical use of the same
    摘要:
    式(I)的杂环酰胺化合物##STR1##,其中每个符号如规范中定义的那样,其药理学上可接受的盐,其药物组合物和其药用。本发明的杂环酰胺化合物及其药理学上可接受的盐对哺乳动物包括人类的胰蛋白酶组具有优越的抑制活性,并可经口或经肠外途径给药。因此,它们可用作胰蛋白酶抑制剂,并可有效预防和治疗由胰蛋白酶引起的各种疾病,如由II型血管紧张素引起的疾病。
    公开号:
    US05948785A1
点击查看最新优质反应信息

文献信息

  • Cis-imidazolines
    申请人:——
    公开号:US20030153580A1
    公开(公告)日:2003-08-14
    The present invention provides compounds according to formula I and formula II and pharmaceutically acceptable salts and esters thereof, having the designations provided herein and which inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity. 1
    本发明提供了根据式I和式II提供的化合物,以及其药学上可接受的盐和酯,具有本文提供的标记,并抑制MDM2蛋白与类p53肽的相互作用,并具有抗增殖活性。
  • I2 mediated one-pot synthesis of 1,2,4-triazoles from amidines and imidates
    作者:Surendra Babu Inturi、Biswajit Kalita、A. Jafar Ahamed
    DOI:10.1016/j.tetlet.2016.04.015
    日期:2016.5
    A one-pot facile synthesis of 3,5-disubstituted-1H-1,2,4-triazole derivatives using I2/Cs2CO3 has been described. The method involves readily available inexpensive reagents and is applicable to a wide range of substrates. The transformation involves one-pot sequential C–N and N–N bond forming reactions with high product yields and selectivity, and offers a new and useful strategy for the synthesis
    已经描述了使用I 2 / Cs 2 CO 3一锅法容易地合成3,5-二取代-1 H -1,2,4-三唑衍生物。该方法涉及容易获得的廉价试剂,并且适用于多种底物。该转化涉及高产率和高选择性的一锅顺序C–N和N–N键形成反应,并为合成3,5-二取代-1 H -1,2,4-提供了新的有用策略三唑衍生物。
  • A mild synthesis of [1,2,4]triazolo[4,3-a]pyridines
    作者:Michael A. Schmidt、Xinhua Qian
    DOI:10.1016/j.tetlet.2013.08.024
    日期:2013.10
    The reaction between 2-hydrazinopyridines and ethyl imidates was examined as a one-pot method for rapidly preparing [1,2,4]triazolo[4,3-a]pyridines. A diverse set of 2-hydrazinopyridines were cyclized with a variety of alkyl- and aryl-substituted ethyl imidates in good yields. The reaction proceeds optimally under mild conditions (50−70 °C) using 1.5 equiv of acetic acid. The electronic and steric
    作为快速制备[1,2,4]三唑并[4,3- a ]吡啶的一锅法,研究了2-肼基吡啶和酰亚胺乙酯之间的反应。用各种烷基取代基和芳基取代的乙基酰亚胺酯以高收率将各种不同的2-肼基吡啶环化。使用1.5当量的乙酸,在温和的条件下(50-70°C),反应可以最佳地进行。肼和亚氨酸酯的电子和位阻性质强烈影响反应速率。当使用高度缺乏电子的2-肼基吡啶时,产物重排为[1,2,4]三唑并[1,5- a ]吡啶。
  • DNA‐Encoded Libraries: Hydrazide as a Pluripotent Precursor for On‐DNA Synthesis of Various Azole Derivatives
    作者:Fei Ma、Jie Li、Shuning Zhang、Yuang Gu、Tingting Tan、Wanting Chen、Shuyue Wang、Peixiang Ma、Hongtao Xu、Guang Yang、Richard A. Lerner
    DOI:10.1002/chem.202100850
    日期:2021.6
    chemical transformation strategy using DNA-conjugated benzoyl hydrazine as a common versatile precursor in azole chemical expansion of DELs. DNA-compatible reactions deriving from the common benzoyl hydrazine precursor showed excellent functional group tolerance with exceptional efficiency in the synthesis of various azoles, including oxadiazoles, thiadiazoles, and triazoles, under mild reaction conditions
    DNA 编码的组合化学文库 (DEL) 技术是一种结合遗传学和化学力量的方法,已成为药物发现的宝贵工具。骨骼多样性在 DEL 应用中起着至关重要的作用,并且在很大程度上依赖于新的 DNA 兼容化学反应。我们在此报告了一种系统发育化学转化策略,该策略使用 DNA 共轭苯甲酰肼作为 DEL 的唑类化学扩展中的通用前体。源自常见苯甲酰肼前体的 DNA 相容反应显示出优异的官能团耐受性,在温和的反应条件下合成各种唑类(包括恶二唑、噻二唑和三唑)时具有出色的效率。
  • Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
    申请人:Edwards Louise
    公开号:US20050272779A1
    公开(公告)日:2005-12-08
    The present invention relates to new compounds of formula I, to pharmaceutical formulations containing the compounds, and to the use of the compounds in the prevention and/or treatment of mGluR5 receptor-mediated disorders.
    本发明涉及公式I的新化合物,包含该化合物的药物配方,以及利用该化合物预防和/或治疗mGluR5受体介导的疾病的用途。
查看更多